Even in Prosperity, Long-Term Investments Are Key

if (n == null) The Scientist - Commentary: Even in Prosperity, Long-Term Investments Are Key The Scientist 13[15]:18, Jul. 19, 1999 Opinion Even in Prosperity, Long-Term Investments Are Key By: Gerald Dinnen Suddenly many of the old threats to the U.S. economy do not seem very threatening. Inflation is nonexistent. The federal deficit has been eliminated. And--at a time when our gross domestic product, productivity, and disposable income are reaching n

Written byGerald Dinnen
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share


Opinion

Suddenly many of the old threats to the U.S. economy do not seem very threatening. Inflation is nonexistent. The federal deficit has been eliminated. And--at a time when our gross domestic product, productivity, and disposable income are reaching new heights--other nations we recently worried about competing against have experienced an economic downturn.

One key to the resurgence of the U.S. economy has been the rapid growth of new science- and technology-based industries, especially those related to the Internet and biotechnology. In both of these cases, substantial federal and private funding gave rise to innovations that make much of today's growth possible.

But future progress in these areas is by no means guaranteed. It will require the same farsighted policies and investments that spawned the current wave of opportunity. Already there are challenges looming that threaten to undermine long-term prospects for growth. With the economy booming, it is critical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies